Structured Opportunities for Connection to Improve Aging-related Loneliness

NCT07708844 | Recruiting

• 1 other identifier: IRB2026-0041
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this early phase clinical trial is to determine the impact of participation in planned social activities among adults 55 years of age or older, who report feelings of loneliness. The main questions the study aims to answer are:

• With the availability of a personalized community activity plan, will patients with loneliness participate in two hours of social activity each week?
• Will 2 hours/week of planned social activities in the community reduce individual reports of loneliness? Participants will meet with a community coordinator to identify community activities of interest to them and then participate, in-person or virtually, in these activities over a 6 month period. Patients will complete a series of surveys at the start of the study and then at 1, 3 and 6 months later.

Conditions

Loneliness

Keywords

Loneliness

Outcome Measures

Primary Outcomes (1)

• Change in Loneliness score

  The primary dependent variable will be change in loneliness as measured by the six-item DeJong Loneliness Scale from baseline to six-months post-social prescription. Scale scores range from 0 to 6 with higher scores representing more loneliness.

  6 months

Study Arms (1)

Social Prescription

EXPERIMENTAL

Personalized Social Prescriptions will be determined from a broad menu of activities available in the community.

Behavioral: Prescribing of community activities; at least 2 hours per week

Interventions

Prescribing of community activities; at least 2 hours per week BEHAVIORAL

Personalized Social Prescriptions will be determined from a broad menu of activities available in the community.

Social Prescription

Eligibility Criteria

• Age: 55 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients 55 years of age or older attending an outpatient visit at an Endeavor Health primary care practice site in Evanston, IL.;
• Screened positive for loneliness (often, some of the time, or occasionally) using the one-item Loneliness Screener;
• Able to provide informed consent for study participation;
• Speaks and understands English language.

You may not qualify if:

• Prisoners, pregnant women, children
• Persons those who are determined to be unable to provide consent
• Non-English speakers

Sponsors & Collaborators

• Endeavor Health: lead

Study Sites (1)

Research Institute

Evanston, Illinois, 60201, United States

RECRUITING

Study Officials

• Susan G Fisher, PhD

  Endeavor Health

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Susan G. Fisher, MS, PhD

CONTACT

224-364-7312; Susan.Fisher@EndeavorHealth.org

Shannah Mwanda, MPH

CONTACT

224-364-7459; Shannah.Mwanda@Endeavorhealth.org

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: VP, Healthcare Delivery Sciences

Model Details: This study will be a quasi-experimental pre-post design based on 'intention-to-treat' principles.

Study Record Dates

• First Submitted: July 13, 2026
• First Posted: July 16, 2026
• Study Start: May 1, 2026
• Primary Completion (Estimated): March 31, 2027
• Study Completion (Estimated): May 1, 2027
• Last Updated: July 17, 2026

Record last verified: 2026-07

Data Sharing

• IPD Sharing: Will share
• Shared Documents: SAP, ICF
• Time Frame: June, 2027 to May, 2030
• Access Criteria: All study documents and de-identified data will be available for 3 years post-study completion ang publication.

Locations

US (1)